Carbamazepine (All indications)

Therapeutic terminations of pregnancy

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S9635
R34265		 Miškov (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2016 Medically induced abortion during pregnancy (anytime or not specified) prospective cohort exposed to other treatment, sick excluded Adjustment: No 2.92 [0.05;155.07] C
excluded (control group) 		0/13   0/37 0 13
ref
S9636
R34269		 Miškov (Carbamazepine) (Controls unexposed, disease free), 2016 Medically induced abortion during pregnancy (anytime or not specified) prospective cohort unexposed, disease free excluded Adjustment: No 10.20 [0.19;536.57] C
excluded (control group) 		0/13   0/128 0 13
ref
S9637
R34273		 Miškov (Carbamazepine) (Controls unexposed, sick), 2016 Medically induced abortion during pregnancy (anytime or not specified) prospective cohort unexposed, sick Adjustment: No 0.28 [0.00;16.82] C 0/13   0/4 0 13
ref
Total 1 studies 0.28 [0.00;16.82] 0 13
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Miškov (Carbamazepine) (Controls unexposed, sick), 2016Miškov, 2016 1 0.28[0.00; 16.82]0130%ROB confusion: criticalROB selection: lowROB classification: moderateROB missing: criticalROB mesure: moderateROB reporting: moderate0.22.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Carbamazepine) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.28[0.00; 16.82]-13 -NAMiškov (Carbamazepine) (Controls unexposed, sick), 2016 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 0.28[0.00; 16.82]-13 -NAMiškov (Carbamazepine) (Controls unexposed, sick), 2016 1 Tags Adjustment   - No  - No 0.28[0.00; 16.82]-13 -NAMiškov (Carbamazepine) (Controls unexposed, sick), 2016 1 All studiesAll studies 0.28[0.00; 16.82]-13 -NAMiškov (Carbamazepine) (Controls unexposed, sick), 2016 10.110.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 9635, 9636

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) Out of scale10.20[0.19; 536.57]-13 -NAMiškov (Carbamazepine) (Controls unexposed, disease free), 2016 1 unexposed, sick controlsunexposed, sick controls Out of scale0.28[0.00; 16.82]-13 -NAMiškov (Carbamazepine) (Controls unexposed, sick), 2016 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 2.92[0.05; 155.07]-13 -NAMiškov (Carbamazepine) (Controls exposed to Lamotrigine, sick), 2016 10.510.01.0